platoseedplatoseed
We break viruses
We make oral drugs to treat and prevent viral infections - like COVID-19.
Pardes Biosciences presents as a company focused on virology, with a tagline suggesting a focus on breaking viruses. The available text is limited to a generic information site description without product-level or market details.
No product-specific information is provided in the given text. The site text only references general information resources and a pricing page, lacking descriptions of how any product or solution works.
Who it’s for: []
Co-founder and the Chief Medical Officer of Assembly Pharma (2012) and CMO/VP R&D for Assembly Biosciences (f\k\a Ventrus Bioscience), which reverse merged with Assembly Pharma in 2014. He helped ASMB raise > $300M to move 2 generations of novel HBV meds into Ph 1 and Ph 2 clinical studies. Uri has held roles at Schering Plough, Roche, and Gilead Science, and received medical training at UMDNJ, NYU and the NIH. Uri was a visiting partner at YC before he started Pardes to cure COVID-19
How Pardes Biosciences’s homepage introduced itself over the years — each line is the page title the web actually saw, linked to that moment’s archived capture.
Using the immune system to cure disease
We’re creating programmable therapies
